SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001764013-24-000203
Filing Date
2024-12-18
Accepted
2024-12-18 17:01:33
Documents
2
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1734559287.html 3  
1 FORM 3 wk-form3_1734559287.xml 3 1730
2 EX-24 imvt-edgarpowerofattorneyx.htm EX-24 8545
  Complete submission text file 0001764013-24-000203.txt   11847
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Issuer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DERMAVANT SCIENCES, INC. 2398 E. CAMELBACK ROAD, SUITE 1060 PHOENIX AZ 85016
Business Address
Van Tuyl Christopher (Reporting) CIK: 0001779707 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38906 | Film No.: 241560113